What Is the Role of Radiofrequency Ablation for Benign Thyroid Nodules?

2021 ◽  
Author(s):  
Peter Horwich ◽  
Brent A. Chang ◽  
Ameya A. Asarkar ◽  
Gregory W. Randolph ◽  
Cherie‐Ann O. Nathan
2018 ◽  
Author(s):  
Raul Rodriguez Escobedo ◽  
Silvia Gonzalez Martinez ◽  
Fernando Garcia Urruzola ◽  
Soraya Lanes Iglesias ◽  
Alicia Martin Nieto ◽  
...  

2020 ◽  
Vol 37 (1) ◽  
pp. 742-748
Author(s):  
Yangsean Choi ◽  
So-Lyung Jung ◽  
Jinhee Jang ◽  
Na-Young Shin ◽  
Kook-Jin Ahn ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lin Yan ◽  
Mingbo Zhang ◽  
Fang Xie ◽  
Jun Ma ◽  
Jing Xiao ◽  
...  

Abstract Background Radiofrequency ablation (RFA) is recommended for the treatment of benign thyroid nodules. However, data on the clinical role of RFA for benign thyroid nodules in patients with history of thyroid lobectomy are insufficient. The purpose of this study was to evaluate the efficacy and safety of radiofrequency ablation (RFA) for benign thyroid nodules in patients who had previously undergoing thyroid lobectomy. Methods From May 2015 to October 2018, a total of 20 patients (19 females, 1 male, mean age 49.50 ± 14.26 years, range 22–74 years) with 20 benign thyroid nodules (mean volume 15.04 ± 21.17 ml, range 0.40–69.67 ml) who had undergone previous thyroid lobectomy were included in this retrospective study. Patients were followed up at 3, 6, 12 months after RFA and every 12 months thereafter by ultrasound, clinical evaluation and thyroid function. Volume, volume reduction rate (VRR), symptom score and cosmetic score were evaluated. Results During the mean follow-up time of 21.24 ± 16.41 months, the mean nodule volume decreased significantly from 15.04 ± 21.17 ml to 1.29 ± 1.17 ml (P = 0.018) with a mean VRR of 85.41 ± 12.17%. Therapeutic success was achieved in a single session for all thyroid nodules. The symptom score (P = 0.001) and cosmetic score (P = 0.001) were both significantly reduced at the last follow-up. The levels of free triiodothyronine (fT3), free thyroxine (fT4) and thyroid stimulating hormone were not significantly different at the last follow-up from those prior to treatment (all P > 0.05). No life-threatening complications or sequelae occurred after RFA. Conclusions As a minimally invasive modality, RFA was a safe, effective, and thyroid function-preserving option for patients with symptomatic benign thyroid nodules after a previous lobectomy.


2021 ◽  
Vol 38 (03) ◽  
pp. 377-381
Author(s):  
Timothy C. Huber ◽  
Auh Whan Park

2015 ◽  
Vol 8 (2) ◽  
pp. 183 ◽  
Author(s):  
Tae Hyun Kim ◽  
Se-Mi Kim ◽  
Ah-Lon Jung ◽  
Seung Ki Moon ◽  
Dong Hoon Yang ◽  
...  

2017 ◽  
Vol Special iss (5) ◽  
Author(s):  
Hojat Ebrahiminik ◽  
Ali Mosaddegh khah ◽  
Ahmadreza Soroush ◽  
Narges Fadaei ◽  
Babak Shekarchi ◽  
...  

2019 ◽  
Vol 34 (2) ◽  
pp. 169 ◽  
Author(s):  
Su Min Ha ◽  
Jun Young Shin ◽  
Jung Hwan Baek ◽  
Dong Eun Song ◽  
Sae Rom Chung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document